Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in vivo.

Hein TW, Singh U, Vasquez-Vivar J, Devaraj S, Kuo L, Jialal I.

Atherosclerosis. 2009 Sep;206(1):61-8. doi: 10.1016/j.atherosclerosis.2009.02.002. Epub 2009 Feb 12.

2.

C-reactive protein inhibits endothelium-dependent NO-mediated dilation in coronary arterioles by activating p38 kinase and NAD(P)H oxidase.

Qamirani E, Ren Y, Kuo L, Hein TW.

Arterioscler Thromb Vasc Biol. 2005 May;25(5):995-1001. Epub 2005 Feb 17.

3.

Endothelial dysfunction in rat adjuvant-induced arthritis: vascular superoxide production by NAD(P)H oxidase and uncoupled endothelial nitric oxide synthase.

Haruna Y, Morita Y, Komai N, Yada T, Sakuta T, Tomita N, Fox DA, Kashihara N.

Arthritis Rheum. 2006 Jun;54(6):1847-55.

4.

C-reactive protein inhibits endothelium-dependent nitric oxide-mediated dilation of retinal arterioles via enhanced superoxide production.

Nagaoka T, Kuo L, Ren Y, Yoshida A, Hein TW.

Invest Ophthalmol Vis Sci. 2008 May;49(5):2053-60. doi: 10.1167/iovs.07-1387.

PMID:
18436840
5.

C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling.

Singh U, Devaraj S, Vasquez-Vivar J, Jialal I.

J Mol Cell Cardiol. 2007 Dec;43(6):780-91. Epub 2007 Aug 31.

6.

Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats.

Sánchez M, Galisteo M, Vera R, Villar IC, Zarzuelo A, Tamargo J, Pérez-Vizcaíno F, Duarte J.

J Hypertens. 2006 Jan;24(1):75-84.

PMID:
16331104
7.

Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.

Bitar MS, Wahid S, Mustafa S, Al-Saleh E, Dhaunsi GS, Al-Mulla F.

Eur J Pharmacol. 2005 Mar 21;511(1):53-64.

PMID:
15777779
8.

Glutathionylation mediates angiotensin II-induced eNOS uncoupling, amplifying NADPH oxidase-dependent endothelial dysfunction.

Galougahi KK, Liu CC, Gentile C, Kok C, Nunez A, Garcia A, Fry NA, Davies MJ, Hawkins CL, Rasmussen HH, Figtree GA.

J Am Heart Assoc. 2014 Apr 22;3(2):e000731. doi: 10.1161/JAHA.113.000731.

9.

3',4'-Dihydroxyflavonol reduces superoxide and improves nitric oxide function in diabetic rat mesenteric arteries.

Leo CH, Hart JL, Woodman OL.

PLoS One. 2011;6(6):e20813. doi: 10.1371/journal.pone.0020813. Epub 2011 Jun 6.

10.

Bone medullary arterioles from ovariectomized rats have smaller baseline diameters but normal eNOS expression and NO-mediated dilation.

Soukhova-O'Hare G, Lei Z, Falcone JC, Barati MT, Feitelson JB, Rao ChV, Fleming JT.

Life Sci. 2005 Aug 26;77(15):1799-812.

PMID:
16019034
11.

Role of NAD(P)H oxidase in alcohol-induced impairment of endothelial nitric oxide synthase-dependent dilation of cerebral arterioles.

Sun H, Zheng H, Molacek E, Fang Q, Patel KP, Mayhan WG.

Stroke. 2006 Feb;37(2):495-500. Epub 2005 Dec 22.

12.

20-hydroxyeicosatetraenoic acid causes endothelial dysfunction via eNOS uncoupling.

Cheng J, Ou JS, Singh H, Falck JR, Narsimhaswamy D, Pritchard KA Jr, Schwartzman ML.

Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H1018-26. Epub 2007 Dec 21.

13.

Chronic administration of genistein improves endothelial dysfunction in spontaneously hypertensive rats: involvement of eNOS, caveolin and calmodulin expression and NADPH oxidase activity.

Vera R, Sánchez M, Galisteo M, Villar IC, Jimenez R, Zarzuelo A, Pérez-Vizcaíno F, Duarte J.

Clin Sci (Lond). 2007 Feb;112(3):183-91.

PMID:
17007611
14.

Adiponectin improves endothelial function in hyperlipidemic rats by reducing oxidative/nitrative stress and differential regulation of eNOS/iNOS activity.

Li R, Wang WQ, Zhang H, Yang X, Fan Q, Christopher TA, Lopez BL, Tao L, Goldstein BJ, Gao F, Ma XL.

Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1703-8. Epub 2007 Sep 25.

15.

Angiostatin: a negative regulator of endothelial-dependent vasodilation.

Koshida R, Ou J, Matsunaga T, Chilian WM, Oldham KT, Ackerman AW, Pritchard KA Jr.

Circulation. 2003 Feb 18;107(6):803-6.

16.

Hindlimb unweighting alters endothelium-dependent vasodilation and ecNOS expression in soleus arterioles.

Schrage WG, Woodman CR, Laughlin MH.

J Appl Physiol (1985). 2000 Oct;89(4):1483-90.

17.

Selective activation of lectin-like oxidized low-density lipoprotein receptor-1 mediates C-reactive protein-evoked endothelial vasodilator dysfunction in coronary arterioles.

Hein TW, Qamirani E, Ren Y, Xu X, Thengchaisri N, Kuo L.

Circ Res. 2014 Jan 3;114(1):92-100. doi: 10.1161/CIRCRESAHA.114.301763. Epub 2013 Oct 18.

18.

Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome.

Picchi A, Gao X, Belmadani S, Potter BJ, Focardi M, Chilian WM, Zhang C.

Circ Res. 2006 Jul 7;99(1):69-77. Epub 2006 Jun 1.

19.

22-Oxacalcitriol prevents progression of endothelial dysfunction through antioxidative effects in rats with type 2 diabetes and early-stage nephropathy.

Hirata M, Serizawa K, Aizawa K, Yogo K, Tashiro Y, Takeda S, Moriguchi Y, Endo K, Fukagawa M.

Nephrol Dial Transplant. 2013 May;28(5):1166-74. doi: 10.1093/ndt/gfs536. Epub 2012 Dec 13.

PMID:
23239833
20.

Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis.

Haruna Y, Morita Y, Yada T, Satoh M, Fox DA, Kashihara N.

Arthritis Rheum. 2007 Jun;56(6):1827-35.

Supplemental Content

Support Center